News

:::
:::
A Novel Imaging-guided High-Intensity Focused Ultrasound System for Treatment of Breast Tumors

A Novel Imaging-guided High-Intensity Focused Ultrasound System for Treatment of Breast Tumors

A Culturally Adapted Treatment Program to Help Recovery from Methamphetamine Addiction in Taiwan

A Culturally Adapted Treatment Program to Help Recovery from Methamphetamine Addiction in Taiwan

Reprogramming Inflammatory Tumor Microenvironment Enhances anti-PD-L1 Cancer Immunotherapy by Vascular Normalization

Reprogramming Inflammatory Tumor Microenvironment Enhances anti-PD-L1 Cancer Immunotherapy by Va

A Novel Tumor Suppressor Regulating Prostate Cancer Metastasis: ROR2 receptor

A Novel Tumor Suppressor Regulating Prostate Cancer Metastasis: ROR2 receptor April 16, 2021 Sc

US FDA approves Taiwan-developed anti-cancer drug-delivery system for phase I clinical study

US FDA approves Taiwan-developed anti-cancer drug-delivery system for phase I clinical study March

NHRI scientists harness nanoparticles to improve use of weight loss drug s by reduc ing their side effects

NHRI has established a novel application of MSNs, enhancing the utility and market development of lipase inhibitor-based anti-obesity drugs by reducing their side effects and elevating life quality

National Health Research Institutes and Millennium Pharmaceuticals, Inc., a wholly-owned subsidiary of Takeda Pharmaceuticals Company Limited, join forces in the area of genome research to develop rar

National Health Research Institutes and Millennium Pharmaceuticals, Inc., a wholly-owned subsidiary o

Sharing Taiwan’s Experience in Areca Nut and Betel Quid Control

Sharing Taiwan’s Experience in Areca Nut and Betel Quid Control December 14, 2020 Or

A Novel Chemotherapy Regimen (SLOG) in Metastatic Pancreatic Cancer with Promising Efficacies

A Novel Chemotherapy Regimen (SLOG) in Metastatic Pancreatic Cancer with Promising Efficacies

A Safer Opioid Painkiller with Low Side-Effects ─NHRI has discovered a series of opioid receptor/nociception receptor dual agonists with fast and potent antinociception, fewer side-effects than morphi

A Safer Opioid Painkiller with Low Side-Effects ─NHRI has discovered a series of opioid receptor/

Current page 1/2 | Total items:11